Robotic Laparoscopic Surgery Patents 2026 — PatSnap Eureka
Robotic Laparoscopic Surgery Technology Landscape 2026
Robotic laparoscopic surgery has evolved from a single-platform market into a multi-vendor competitive arena driven by AI integration, 3D imaging, and 5G-enabled telesurgery. This dataset snapshot covers key patent filings and literature from pre-2000 through January 2026.
From Single-Platform Monopoly to Multi-Vendor AI-Driven Surgery
Robotic laparoscopic surgery integrates articulated robotic arms, endoscopic imaging, surgeon consoles, and AI-driven control systems to perform minimally invasive procedures. The da Vinci system pioneered wristed instrument articulation, tremor filtering, and motion scaling, establishing the master-slave architecture as the dominant paradigm since the late 1990s.
Patent expiry has opened the competitive space. The Korean Revo-i platform, developed by Meerecompany, achieved commercial launch and is documented as operating across gynecology, urology, and general surgery globally as of 2021. South Korea is actively building domestic robotic surgery manufacturing capability as a direct challenge to Western incumbents.
The most advanced current filings target integrated intelligence layers: a 2026 US patent from Genesis MedTech International discloses a dynamic 3D scanning laparoscope connected to a Digital Health Platform enabling AR visualization, VR surgical reconstruction, and AI/ML model training from intraoperative scan data — signaling a shift toward networked surgical intelligence.
In retrieved records, Genesis MedTech International holds 3 of the 4 patent filings in this dataset, covering dynamic 3D scanning robotic laparoscopes across US and WO jurisdictions. Meenakshi Academy of Higher Education and Research contributes 1 pending Indian patent on telemedicine-enabled robotic surgery with haptic feedback, reflecting growing academic-origin IP from India.
Technology Clusters and Application Domain Distribution
Four primary technology clusters are identifiable within this dataset: advanced visualization and 3D imaging, telesurgery and haptic feedback, AI-augmented robotic control, and multi-platform competitive systems. Application domains span gynecology, urology, general surgery, thoracic surgery, and emerging specialty areas.
Technology Cluster Distribution — Retrieved Patent Filings (Dataset Snapshot)
In this dataset, visualization and 3D imaging patents account for 3 of 4 filings, reflecting Genesis MedTech’s focused IP strategy; telesurgery and haptic feedback accounts for 1 filing from Meenakshi Academy.
↗ Click bars to exploreRobotic Surgery Application Domain Activity — Literature Coverage by Domain
In this dataset, urology and gynecology are the most heavily documented application domains in retrieved literature, with urology representing 84.2% of NHS robotic procedures and gynecology documented across multi-institutional Indian data spanning 2011–2021.
↗ Click bars to exploreKey Surgical Domains and Geographic Deployment in Robotic Laparoscopy
Robotic laparoscopic surgery has been documented across at least six major surgical application domains in this dataset, with urology and gynecology representing the highest-volume and most extensively documented areas. Geographic deployment spans the US, UK, India, South Korea, and parts of the Middle East.
England NHS Robotic Urology
Urological procedures constitute 84.2% of all robotic procedures across England’s NHS, per a Freedom of Information analysis documented in this dataset. Robotic-assisted radical prostatectomy adoption in the US rose from 0.7% to 42% of prostatectomies between 2003 and 2010, with current estimates approaching 80%. As of 2020, 61 robotic systems were deployed across 48 NHS trusts in England.
In-situ NetworkIndia Five-Hospital Gynecology Cohort
Multi-institutional Indian data from five tertiary hospitals covering 2011–2021 documents a decade of growth in robotic gynecologic surgery, published as a 2023 literature source in this dataset. Procedures include robotic total laparoscopic hysterectomy, myomectomy, sacrocolpopexy, lymph node dissection, and endometriosis surgery. The da Vinci system received FDA approval for gynecologic use in 2005.
GHG Flux MonitoringUS Bariatric Surgery Program 2015–2020
A 2022 analysis of the US Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program covering 2015–2020 documents rising robotic adoption in bariatric procedures including robotic sleeve gastrectomy and Roux-en-Y gastric bypass. This literature source is retrieved in this dataset. Robotic liver surgery and robotic gastrectomy for gastric cancer are also documented application areas within the same general surgery domain.
AI AssessmentIndia Telesurgery Patent 2025
Meenakshi Academy of Higher Education and Research filed a 2025 Indian patent disclosing a telemedicine-enabled robotic surgery system with multi-modal haptic feedback combining tactile, vibrational, and thermal channels. The system integrates AI-based trajectory prediction to compensate for network latency, redundant 5G/satellite/fiber communications, and a blockchain-based surgical audit module. This pending patent (IN, 2025) is one of four retrieved filings in this dataset.
Remote SensingKey Patent Assignees in Robotic Laparoscopic Surgery (Retrieved Records)
In retrieved records, two assignees account for all 4 patent filings in this dataset: Genesis MedTech International Private Limited (and its US subsidiary Genesis MedTech (USA) Inc.) holds 3 filings focused on dynamic 3D scanning laparoscopes, while Meenakshi Academy of Higher Education and Research holds 1 pending Indian filing on telesurgery with haptic feedback.
Assignee Filing Counts — Robotic Laparoscopic Surgery (Dataset Snapshot)
↗ Click bars to exploreGenesis MedTech International
Genesis MedTech International Private Limited holds 3 patent filings in this dataset (US active ×2, WO ×1), spanning 2023 to January 2026. All three filings cover the Dynamic 3D Scanning Robotic Laparoscope, which integrates a 3D scanner into the laparoscope for real-time AR visualization, VR reconstruction, and AI/ML model development. The January 2026 US grant confirms active prosecution with international WO coverage extending protection globally.
United States / WOMeenakshi Academy of Higher Education
Meenakshi Academy of Higher Education and Research holds 1 pending patent filing (IN, 2025) in this dataset, covering a telemedicine-enabled robotic surgery system with multi-modal haptic feedback. The patent discloses AI-based trajectory prediction for network latency compensation, redundant 5G/satellite/fiber communications, and a blockchain-based surgical audit module. This represents academic-origin IP from India’s private higher education sector with pending status as of 2025.
India — INNext Frontiers in Robotic Laparoscopic Surgery (2023–2026)
The most recent filings and literature in this dataset (2023–2026) identify five emerging directions: AI-integrated intraoperative navigation, telesurgery infrastructure with AI latency compensation, multi-modal haptic feedback convergence, miniaturization and micro-robotics, and standardized AI-powered surgical training.
AI-Integrated Digital Health Platforms
The Genesis MedTech 2026 US patent explicitly connects the robotic laparoscope to a Digital Health Platform enabling VR surgical reconstruction, AR visualization, and AI/ML model training from intraoperative 3D scan data. This signals a shift from isolated robotic systems to networked surgical intelligence platforms. The dual US/WO filing strategy suggests active international IP protection of this architecture.
Telesurgery AI Latency Compensation and Blockchain Audit
The 2025 Indian patent from Meenakshi Academy discloses AI-based predictive stability engines that proactively compensate for network-induced delays — the principal technical barrier to clinically viable long-distance telesurgery. Blockchain-based surgical audit trails are introduced as a novel safety and regulatory compliance layer. Literature from 2021 documents the first live robotic telesurgery demonstration on the da Vinci Research Kit with motion scaling as a bench-to-bedside milestone.
Genesis MedTech 3D Laparoscope vs. Meenakshi Academy Telesurgery System
Click any row to explore further.
| Dimension | Genesis MedTech 3D Scanning Laparoscope | Meenakshi Academy Telesurgery System |
|---|---|---|
| Assignee | Genesis MedTech International Private Limited / Genesis MedTech (USA) Inc. | Meenakshi Academy of Higher Education and Research |
| Jurisdiction | US (active ×2), WO ×1 | India — IN (pending) |
| Filing Dates | 2023 (×2), January 2026 (×1) | November 2025 |
| Core Technology | Dynamic 3D scanner integrated into laparoscope; AR visualization; VR reconstruction; AI/ML training data generation; Digital Health Platform | Multi-modal haptic feedback (tactile, vibrational, thermal); AI trajectory prediction for latency compensation; redundant 5G/satellite/fiber comms; blockchain surgical audit module |
| Primary Use | Intraoperative navigation, AR overlay, real-time surgical guidance, diagnostic data generation | Long-distance telesurgery with clinically acceptable latency and surgeon tactile feedback |
| Patent Status | Active (US granted January 2026; 2023 US active; 2023 WO) | Pending (IN, 2025) |
| Safety Architecture | Real-time 3D spatial reference coordinate system for surgical accuracy | Safety braking module halts robotic arm when unsafe network delays detected; blockchain audit trail for regulatory compliance |
| Origin Type | Commercial medtech company (US/international) | Academic institution — private higher education sector, India |
Frequently Asked Questions — Robotic Laparoscopic Surgery Patents 2026
This dataset identifies four primary technology clusters: (1) Advanced Visualization and 3D Imaging Integration — covering dynamic 3D scanning laparoscopes with AR overlays and AI/ML training; (2) Telesurgery, Haptic Feedback, and Remote Operational Architecture; (3) AI-Augmented Robotic Control and Autonomous Surgical Assistance (documented primarily in literature); and (4) Multi-Platform Competitive Robotic Systems and Single-Port Architectures.
Two assignees appear in the 4 retrieved patent filings: Genesis MedTech International Private Limited (and its subsidiary Genesis MedTech (USA) Inc.) holds 3 filings on dynamic 3D scanning robotic laparoscopes across US and WO jurisdictions. Meenakshi Academy of Higher Education and Research holds 1 pending Indian patent (2025) on telemedicine-enabled robotic surgery with haptic feedback.
The January 2026 US patent from Genesis MedTech International discloses a dynamic 3D scanning robotic laparoscope that integrates a 3D scanner directly into the laparoscope, providing real-time surgical navigation, augmented reality visualization, VR surgical reconstruction, and AI/ML model development and training from intraoperative 3D scan data — connected to a Digital Health Platform.
The 2025 pending Indian patent from Meenakshi Academy discloses: multi-modal haptic feedback combining tactile, vibrational, and thermal channels; AI-based trajectory prediction to compensate for network latency; redundant communications channels combining 5G, satellite, and fiber; a safety braking module that halts robotic arm motion when unsafe delays are detected; and a blockchain-based audit module for surgical safety and regulatory compliance.
Urology has the highest documented adoption, with urological procedures constituting 84.2% of all robotic procedures in England’s NHS. Robotic-assisted radical prostatectomy reached approximately 80% of all US prostatectomies. Gynecology is the second most documented domain, with the da Vinci system receiving FDA approval for gynecologic use in 2005 and multi-institutional Indian data documenting decade-long growth from 2011 to 2021.
India and South Korea are identified as emerging IP originators. Two of the four patent filings in this dataset originate from Indian entities (Genesis MedTech, Meenakshi Academy). South Korea’s Meerecompany commercialized the Revo-i robotic surgery platform, documented as the first Korean surgical robot for laparoscopic procedures, competing globally in gynecology, urology, and general surgery as of 2021.
Data and insights on this page are based on a limited patent and literature dataset and are for reference only. Figures may not represent the complete technology landscape.